Biomarkers in Brain Disease
31 – 40 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
White adipose tissue browning in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
-
Mark
Brown is the new white: consequences of white adipose tissue alterations in Huntington's disease
2016)(
- Thesis › Doctoral thesis (compilation)
- 2015
-
Mark
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
(
- Contribution to journal › Article
-
Mark
Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.
(
- Contribution to journal › Article
- 2014
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Flt3 ligand does not differentiate between Parkinsonian disorders.
(
- Contribution to journal › Article